Several of Interventional News’ most read stories from April covered the topic of interventional oncology (IO)—its interrelation with immuno-oncology, a robot-assisted lung metastases treatment, and articles featuring analysis of current guidelines for cancers in the liver and kidneys. The profile of Theresa Caridi from the latest print issue also grabbed readers’ attention this month, as did three stories focused on peripheral arterial treatments.
1) AVS’s pulsatile IVL technology attracts an additional US$8.8 million to close US$28.8 million Series B round
AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its pulsatile intravascular lithotripsy (PIVL) therapy, has announced that it closed an additional US$8.8 million in new financing, bringing its Series B round to US$28.8 million total.
2) SIR 2023 puts spotlight on Latin American IR
A session at the Society of Interventional Radiology (SIR) annual scientific meeting (4–9 March, Phoenix, USA) put the focus on the landscape of interventional radiology (IR) in Latin America and the initiatives that SIR has implemented to strengthen IR worldwide, including in South and Central America.
3) IO beyond interventional oncology: Progress in immuno-oncology
Antonia Digklia, a specialist in medical and interventional oncology at the Centre hospitalier universitaire de Lausanne (Lausanne, Switzerland) tells Interventional News how recent advances in immuno-oncology are transforming the practice of medical oncology.
4) ESRD strongly associated with adverse limb events in new study
A new investigation into the association between end-stage renal disease (ESRD) and major adverse limb events has found that not only is it strong, but ESRD is particularly associated with below-knee amputation.
5) Surmodics announces successful first patient use of Sublime radial access microcatheter designed for the periphery
Surmodics has announced that Ankur Lodha (Cardiovascular Institute of the South, Lafayette, USA) and Pradeep Nair (Cardiovascular Institute of the South, Houma, USA) were the first physicians to use the company’s Sublime radial access microcatheter.
Theresa Caridi is an interventional radiologist based at the University of Alabama at Birmingham (UAB; Birmingham, USA), where she is Interventional Radiology (IR) Division director. She recounts some of the key points on her IR career journey to date for Interventional News.
7) Clinical trial continuation announced for robot-assisted treatment for lung metastases
Quantum Surgical has announced the ongoing clinical trial for the treatment of lung metastases assisted by the Epione robot.
8) First patient enrolled in PROWL registry using Pounce thrombectomy system
Surmodics has announced enrolment of the first patient in PROWL, the Pounce thrombectomy system retrospective registry. The Pounce system is indicated for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
9) Cryoablation for RCC: Where do we stand? Where are we going?
Christos Georgiades (Johns Hopkins University, Baltimore, USA), delves into the various national society guidelines for treating renal cell carcinoma (RCC) for Interventional News readers, recommending what he believes is the route to ensuring the best outcomes for patients.
10) The hot topic of colorectal metastases gets airtime at ECIO 2023
Alessandro Vitale (University of Padua, Padua, Italy) presented current advice and practice concerning bridging colorectal liver metastases (CRLM) to liver transplantation at the European Conference on Interventional Oncology (ECIO; 16–19 April, Stockholm, Sweden).